Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001816736-25-000007
Filing Date
2025-08-07
Accepted
2025-08-07 08:40:50
Documents
66
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q iron-20250630.htm   iXBRL 10-Q 2618549
2 EX-31.1 iron-ex31_1.htm EX-31.1 16670
3 EX-31.2 iron-ex31_2.htm EX-31.2 16331
4 EX-32.1 iron-ex32_1.htm EX-32.1 10016
  Complete submission text file 0001816736-25-000007.txt   9234814

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT iron-20250630.xsd EX-101.SCH 1423582
69 EXTRACTED XBRL INSTANCE DOCUMENT iron-20250630_htm.xml XML 1365636
Mailing Address 321 ARSENAL STREET, SUITE 101 WATERTOWN MA 02472
Business Address 321 ARSENAL STREET, SUITE 101 WATERTOWN MA 02472 (617) 674-9274
Disc Medicine, Inc. (Filer) CIK: 0001816736 (see all company filings)

EIN.: 851613057 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)